Schernthaner G - Search Results

1

Variability in and predictors of glycaemic responses after 24 weeks of treatment with exenatide twice daily and exenatide once weekly.

Shaw JE, Gallwitz B, Han J, Hardy E, Schernthaner G. Shaw JE, et al. Among authors: schernthaner g. Diabetes Obes Metab. 2017 Dec;19(12):1793-1797. doi: 10.1111/dom.13022. Epub 2017 Jul 25. Diabetes Obes Metab. 2017. PMID: 28573708 Free PMC article.

2

Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial.

Gallwitz B, Guzman J, Dotta F, Guerci B, Simó R, Basson BR, Festa A, Kiljański J, Sapin H, Trautmann M, Schernthaner G. Gallwitz B, et al. Among authors: schernthaner g. Lancet. 2012 Jun 16;379(9833):2270-8. doi: 10.1016/S0140-6736(12)60479-6. Epub 2012 Jun 9. Lancet. 2012. PMID: 22683137 Clinical Trial.

3

Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study.

Simó R, Guerci B, Schernthaner G, Gallwitz B, Rosas-Guzmàn J, Dotta F, Festa A, Zhou M, Kiljański J. Simó R, et al. Among authors: schernthaner g. Cardiovasc Diabetol. 2015 Sep 4;14:116. doi: 10.1186/s12933-015-0279-z. Cardiovasc Diabetol. 2015. PMID: 26338040 Free PMC article. Clinical Trial.

4

Contribution of insulin deficiency and insulin resistance to the development of type 2 diabetes: nature of early stage diabetes.

Gallwitz B, Kazda C, Kraus P, Nicolay C, Schernthaner G. Gallwitz B, et al. Among authors: schernthaner g. Acta Diabetol. 2013 Feb;50(1):39-45. doi: 10.1007/s00592-011-0319-4. Epub 2011 Aug 23. Acta Diabetol. 2013. PMID: 21861172

5

Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: the randomized MARLINA-T2D trial.

Groop PH, Cooper ME, Perkovic V, Hocher B, Kanasaki K, Haneda M, Schernthaner G, Sharma K, Stanton RC, Toto R, Cescutti J, Gordat M, Meinicke T, Koitka-Weber A, Thiemann S, von Eynatten M. Groop PH, et al. Among authors: schernthaner g. Diabetes Obes Metab. 2017 Nov;19(11):1610-1619. doi: 10.1111/dom.13041. Epub 2017 Jul 31. Diabetes Obes Metab. 2017. PMID: 28636754 Free PMC article. Clinical Trial.

6

Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19 (Diabetes Metab J 2021;45:251-9).

Schernthaner G. Schernthaner G. Diabetes Metab J. 2021 Jul;45(4):615-616. doi: 10.4093/dmj.2021.0081. Epub 2021 Jul 30. Diabetes Metab J. 2021. PMID: 34352990 Free PMC article. No abstract available.

7

Endothelial progenitor cells are related to glycemic control in children with type 1 diabetes over time.

Hörtenhuber T, Rami-Mehar B, Satler M, Nagl K, Höbaus C, Höllerl F, Koppensteiner R, Schernthaner G, Schober E, Schernthaner GH. Hörtenhuber T, et al. Among authors: schernthaner gh, schernthaner g. Diabetes Care. 2013 Jun;36(6):1647-53. doi: 10.2337/dc12-1206. Epub 2013 Jan 22. Diabetes Care. 2013. PMID: 23340890 Free PMC article.

8

Sodium-glucose linked transporter-2 inhibitor renal outcome modification in type 2 diabetes: Evidence from studies in patients with high or low renal risk.

Schernthaner G, Groop PH, Kalra PA, Ronco C, Taal MW. Schernthaner G, et al. Diabetes Obes Metab. 2020 Jul;22(7):1024-1034. doi: 10.1111/dom.13994. Epub 2020 Mar 2. Diabetes Obes Metab. 2020. PMID: 32037647 Review.

9

Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study.

Buse JB, Nauck M, Forst T, Sheu WH, Shenouda SK, Heilmann CR, Hoogwerf BJ, Gao A, Boardman MK, Fineman M, Porter L, Schernthaner G. Buse JB, et al. Among authors: schernthaner g. Lancet. 2013 Jan 12;381(9861):117-24. doi: 10.1016/S0140-6736(12)61267-7. Epub 2012 Nov 7. Lancet. 2013. PMID: 23141817 Clinical Trial.

10

Miglitol combined with metformin improves glycaemic control in type 2 diabetes.

Van Gaal L, Maislos M, Schernthaner G, Rybka J, Segal P. Van Gaal L, et al. Among authors: schernthaner g. Diabetes Obes Metab. 2001 Oct;3(5):326-31. doi: 10.1046/j.1463-1326.2001.00141.x. Diabetes Obes Metab. 2001. PMID: 11703422 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

595 results

Search Page